DNA methylation, a biomarker for colorectal cancer: implications for screening and pathological utility

AM Jubb, P Quirke, AJ Oates - … of the New York Academy of …, 2003 - Wiley Online Library
Currently up to one‐third of colorectal cancer patients present with locally advanced or
metastatic disease that precludes a surgical cure. Performance limitations and low uptake of …
被引用次数：47 相关文章

DNA Methylation, a Biomarker for Colorectal Cancer

AM JUBB, P QUIRKE, AJ OATES - Annals of the New York Academy of …, 2003 - cir.nii.ac.jp
抄録< jats: p>< jats: bold> A< jats: sc> bstract</jats: sc>:</jats: bold> Currently up to one‐
third of colorectal cancer patients present with locally advanced or metastatic disease that …

DNA methylation, a biomarker for colorectal cancer: implications for screening and pathological utility.

AM Jubb, P Quirke, AJ Oates - Annals of the New York Academy of …, 2003 - europepmc.org
Currently up to one-third of colorectal cancer patients present with locally advanced or
metastatic disease that precludes a surgical cure. Performance limitations and low uptake of …

DNA methylation, a biomarker for colorectal cancer: implications for screening and pathological utility

AM Jubb, P Quirke, AJ Oates - Annals of the New York …, 2003 - pubmed.ncbi.nlm.nih.gov
Currently up to one-third of colorectal cancer patients present with locally advanced or
metastatic disease that precludes a surgical cure. Performance limitations and low uptake of …

[引用][C] DNA Methylation, a Biomarker for Colorectal Cancer

AM Jubb, P Quirke, AJ Oates - … of the New York Academy of …, 2003 - ui.adsabs.harvard.edu
DNA Methylation, a Biomarker for Colorectal Cancer - NASA/ADS Now on home page ads icon
ads Enable full ADS view NASA/ADS DNA Methylation, a Biomarker for Colorectal Cancer …